The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Mind Medicine Inc shares valued at $142,942 were sold by Barrow Robert on Mar 25 ’25. At $6.74 per share, Barrow Robert sold 21,208 shares. The insider’s holdings dropped to 856,556 shares worth approximately $6.25 million following the completion of this transaction.
Also, Karlin Daniel sold 6,836 shares, netting a total of over 46,075 in proceeds. Following the sale of shares at $6.74 each, the insider now holds 446,177 shares.
Before that, Sullivan Mark had sold 6,576 shares from its account. In a trade valued at $44,322, the Chief Legal Officer traded Mind Medicine Inc shares for $6.74 each. Upon closing the transaction, the insider’s holdings decreased to 6,576 shares, worth approximately $2.31 million.
As published in their initiating research note from Evercore ISI on January 28, 2025, Mind Medicine Inc [MNMD] has been an Outperform and the price target has been revised to $23. Analysts at Chardan Capital Markets started covering the stock with ‘”a Buy”‘ outlook in a report released in mid December. Earlier on July 24, 2024, ROTH MKM initiated its rating. Their recommendation was “a Buy” for MNMD stock.
Analyzing MNMD Stock Performance
On last trading session,, Mind Medicine Inc [NASDAQ: MNMD] plunged -1.35% to $7.30. The stock’s lowest price that day was $7.1907, but it reached a high of $7.4923 in the same session. During the last five days, there has been a drop of approximately -5.07%. Over the course of the year, Mind Medicine Inc shares have jumped approximately 4.89%.
Support And Resistance Levels for Mind Medicine Inc (MNMD)
RSI (Relative Strength Index) is 52.71 on the 14-day chart, showing neutral technical sentiment.
Is Mind Medicine Inc subject to short interest?
Stocks of Mind Medicine Inc saw a sharp rise in short interest on 2025-05-30 jumping by 1.04 million shares to 11.78 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 10.74 million shares. A jump of 8.85% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 9.89 of the overall float, the days-to-cover ratio (short ratio) jumped to 9.89.
Which companies own the most shares of Mind Medicine Inc (MNMD)?
In terms of Mind Medicine Inc share price expectations, FactSet research, analysts set an average price target of 16 in the next 12 months, up nearly 116.22% from the previous closing price of $7.40. Analysts anticipate Mind Medicine Inc stock to reach 16 by 2025, with the lowest price target being 16. In spite of this, 2 analysts ranked Mind Medicine Inc stock as Buy at the end of 2025. On May 29, 2024, Robert W. Baird assigned a price target of “an Outperform” to the stock and initiated coverage with a $27.
